Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/0I0X stock hub

LON/0I0X has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0I0Xis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
190.1M
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0I0X
In the news

Latest news · LON/0I0X

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 16.9P75 23.5
Trailing P/En/a
P25 15.9P50 22.9P75 35.8
ROE-68.9
P25 -54.2P50 2.1P75 13.7
ROIC-14.4
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0I0X market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
177
Groups with data
11
Currency
USD
Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United States
Country code
UK
Employees
146
Employees Change
14%
Employees Change Percent
8.05
Enterprise value
$195.8M
Exchange
London Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biotechnology
Isin
US1920051067
Last refreshed
2026-05-10
Market cap
$190.1M
Price
$2.85
Price currency
USD
Rev Per Employee
405,064.81x
Sector
Healthcare
Sic
2836
Symbol
lon/0I0X
Website
https://www.codexis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-12.74%
EV Earnings
-8.08x
EV/FCF
-11.69x
EV/Sales
3.42x
FCF yield
-8.81%
P/B ratio
5.81x
P/S ratio
3.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
-33.15%
EBITDA Margin
-26.32%
Gross margin
23.83%
Gross Profit
$14.1M
Gross Profit Growth3 Y
55.54%
Gross Profit Growth5 Y
8.79%
Net Income
$-24.2M
Net Income Growth Quarters
4%
Net Income Growth Years
2%
Pretax Margin
-40.87%
Profit Margin
-40.96%
Profit Per Employee
$-165,933
ROA
-12.53
Roa5y
-14.69
ROCE
-22.61
ROE
-68.9
Roe5y
-52.05
ROIC
-14.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr1y
26.22%
Cagr3y
-9.13%
Cagr5y
-34.15%
EPS Growth Quarters
4
EPS Growth Years
2
Revenue Growth
56.76x
Revenue Growth Q
102.15x
Revenue Growth Quarters
2x
Revenue Growth Years
1x
Revenue Growth3 Y
-12.42x
Revenue Growth5 Y
1.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
$0.6
Assets
$98M
Cash
$49.3M
Current Assets
$58.4M
Current Liabilities
$10.9M
Debt
$55.2M
Debt Equity
$1.69
Debt FCF
$-3.3
Equity
$32.7M
Interest Coverage
-5.33
Liabilities
$65.2M
Long Term Assets
$39.5M
Long Term Liabilities
$54.3M
Net Cash
$-5.9M
Net Cash By Market Cap
$-3.09
Net Debt Equity
$0.18
Tangible Book Value
$30.9M
Tangible Book Value Per Share
$0.34
WACC
13.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
5.36
Inventory Turnover
31.46
Net Working Capital
$2.2M
Quick ratio
4.93
Working Capital
$49.1M
Working Capital Turnover
$0.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-16.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
26.2%
200-day SMA
2.08
3Y total return
-24.97%
50-day SMA
1.97
50-day SMA vs 200-day SMA
50under200
5Y total return
-87.61%
All Time High
41.36
All Time High Change
-93.11%
All Time High Date
2021-11-05
All Time Low
0.96
All Time Low Change
195.57%
All Time Low Date
2026-03-04
ATR
0.21
Beta
2.08
Ch YTD
73.74
High
2.91
High52
3.85
High52 Date
2025-08-14
High52ch
-25.95%
Low
2.56
Low52
0.96
Low52 Date
2026-03-04
Low52ch
195.57%
Ma50ch
44.87%
Price vs 200-day SMA
37.07%
RSI
64.01
RSI Monthly
47.41
RSI Weekly
68.73
Sharpe ratio
0.51x
Sortino ratio
0.89
Total Return
-16.57%
Tr YTD
73.77
Tr1m
45.46%
Tr1w
4.06%
Tr3m
115.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
$-19.6M
Operating margin
-33.15

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
72,979,892%
Net Borrowing
7,259,588.1
Shares Insiders
7.04%
Shares Institutions
60.46%
Shares Qo Q
-0.15%
Shares Yo Y
16.57%
Short Ratio
2.6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

51
MetricValue
Adjusted FCF
$-23.3M
Average Volume
18,269.95x
Bv Per Share
0.36
CAPEX
$-2.6M
Ch1m
45.46
Ch1w
4.06
Ch1y
26.21
Ch3m
115.8
Ch3y
-24.97
Ch5y
-87.61
Ch6m
71.24
Change
5.01%
Change From Open
8.41
Close
2.72
Days Gap
-3.13
Depreciation Amortization
3,916,231.2
Dollar Volume
61,786.2
Earnings Date
2026-05-07
EBIT
$-19.6M
EBITDA
$-15.6M
EPS
$-0.27
F Score
4
FCF
$-16.8M
FCF EV Yield
-8.55x
Financing CF
20,317,736
Fiscal Year End
December
Founded
2,002
Goodwill
1,806,645
Income Tax
$54,526
Investing CF
8,044,094
Is Primary Listing
0
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Ma150
1.87
Ma150ch
52.47%
Ma20
2.62
Ma20ch
8.9%
Net CF
14,179,022
Open
2.63
Position In Range
83.17
Ppne
30,920,549.2
Price Date
2026-05-08
Ptbv Ratio
6.16
Relative Volume
1.26x
Revenue
59,139,462x
SBC By Revenue
11.11x
Share Based Comp
6,568,106
Tax By Revenue
0.09x
Tr6m
71.24%
Volume
21,671
Z Score
-4.82
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does LON/0I0X pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0I0X stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+26.2%
S&P 500 1Y: n/a
3Y total return
-25.0%
S&P 500 3Y: n/a
5Y total return
-87.6%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0I0X?

Insider, institutional, and short-interest positioning.

Institutional ownership
+60.5%
Share of float held by funds and institutions
Insider ownership
+7.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
2.6 days to cover
Y/Y dilution
+16.6%
Negative means the company is buying back shares.
Technical

LON/0I0X momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
64.0
Neutral momentum band
Price vs 200-day MA
+37.1%
50/200-day relationship not available
Beta (5Y)
2.08
More volatile than the market
Sharpe ratio
0.51
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0I0X

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0I0X stock rating?

lon/0I0X is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0I0X analysis?

The full report lives at /stocks/lon/0I0X/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0I0X?

The latest report frames lon/0I0X around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0I0X page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

lon/0I0X stock profile: metrics, valuation and analysis | دستیار هوشمند بازار سهام